Landscapes / Targets
CCR8
10 drugs act on CCR8, in 19 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs10
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | Dec 2027Phase 1/2 trial completes | |||
| Next date | Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Advanced Pancreatic Cancer and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Sep 2027Phase 1/2 trial completes | |||
| Next date | Sep 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 May 2028Phase 1/2 trial completes | |||
| Next date | 31 May 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumors | ||||
| Open drug page | |||||
Tagmokitugnot checked |
Unmodified immunoglobulin |
Phase 1/2 | Aug 2028Phase 1/2 trial completes | ||
| How it works | An antibody | ||||
| Next date | Aug 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma and 2 more | ||||
| Open drug page | |||||
Unmodified immunoglobulin |
Bristol Myers Squibb · Public BMY |
Phase 2 | 15 Sep 2028Phase 2 trial completes | ||
| How it works | An antibody | ||||
| Next date | 15 Sep 2028 · Phase 2 trial completes | ||||
| Also tested for | Cervical Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma and 11 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 26 Dec 2028Phase 1/2 trial completes | |||
| Next date | 26 Dec 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced or Metastatic Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1/2 | 30 Dec 2028Phase 1/2 trial completes | |||
| Next date | 30 Dec 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Apr 2027Phase 1 trial completes | |||
| Next date | 30 Apr 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Dec 2027Phase 1 trial completes | |||
| Next date | 31 Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Advanced Cancer and 1 more | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Advanced Solid Tumors and Hematologic Malignancies | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 9 of 10 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026